<DOC>
	<DOCNO>NCT02620397</DOCNO>
	<brief_summary>This trial design prospective , multi-center , observational study `` all-comers '' eligible adult subject present participate emergency department symptom suggestive acute coronary syndrome ( ACS )</brief_summary>
	<brief_title>Clinical Study Validate Use New Point Care Troponin I Test</brief_title>
	<detailed_description>This trial design prospective , multi-center , observational study `` all-comers '' eligible adult subject present participate Emergency Departments ( EDs ) symptom suggestive ACS and/or myocardial ischemia . Subjects present symptom suggestive ACS screen approached consent study enrollment train personnel . After obtain write informed consent , subject 4 blood sample collect cTnI test use Meritas Troponin I test Meritas point-of-care ( POC ) Analyzer . Blood draw test occur 4 interval 24 hour .</detailed_description>
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Acute Coronary Syndrome</mesh_term>
	<criteria>1 . The informed consent must sign subject , subject 's legal authorize representative . 2 . 21 year age great time enrollment 3 . Subjects present ED symptom suggestive ACS and/or myocardial ischemia , limited : subject currently chest pain , pressure burn sensation across precordium epigastrium , pain radiates neck , shoulder , jaw , back , upper abdomen either arm . 1 . Informed consent form sign 2 . Age &lt; 21 year 3 . Known pregnancy</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2015</verification_date>
</DOC>